Orchid Pharma Limited (NSE:ORCHPHARMA)
India
· Delayed Price · Currency is INR 704.50
-9.60 (-1.34%)
Jun 16, 2025, 3:30 PM IST
Orchid Pharma Market Cap
Orchid Pharma has a market cap or net worth of 35.73 billion as of June 16, 2025. Its market cap has decreased by -31.57% in one year.
Market Cap
35.73B
Enterprise Value
35.68B
Revenue
9.22B
Ranking
n/a
PE Ratio
35.85
Stock Price
704.50
Market Cap Chart
Since November 3, 2020, Orchid Pharma's market cap has increased from 727.35M to 35.73B, an increase of 4,812.59%. That is a compound annual growth rate of 132.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2025 | 35.73B | -61.01% |
| Dec 31, 2024 | 91.65B | 153.62% |
| Dec 29, 2023 | 36.14B | 143.20% |
| Dec 30, 2022 | 14.86B | -7.81% |
| Dec 31, 2021 | 16.12B | 223.64% |
| Dec 31, 2020 | 4.98B | 584.72% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,049.60B |
| Divi's Laboratories | 1,769.88B |
| Cipla | 1,215.74B |
| Apollo Hospitals Enterprise | 1,005.70B |
| Mankind Pharma | 982.83B |
| Zydus Lifesciences | 981.03B |
| Aurobindo Pharma | 668.04B |
| Alkem Laboratories | 579.59B |